Bias: Considerations for research practice

American Journal of Health-System Pharmacy

Volumn 65, Issue 22, 2008, Pages 2159-2168

  Gerhard, Tobias ^a,b  

^a and Aging Research

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Clinical studies; Errors; Methodology; Quality assurance; Research

Indexed keywords

CLINICAL RESEARCH; HEALTH CARE; MEASUREMENT ERROR; METHODOLOGY; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PHARMACY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SYSTEMATIC ERROR;

EID: 56749156653     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070369     Document Type: Review

References (29)

1. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
2. Nelson HD, Humphrey LL, Nygren P et al. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002; 288:872-81.
3. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288:321-33.
4. Garbe E, Suissa S. Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum Reprod. 2004; 19:8-13.
5. Prentice RL, Langer R, Stefanick ML et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol. 2005; 162:404-14.
6. Maclure M, Schneeweiss S. Causation of bias: the episcope. Epidemiology. 2001; 12:114-22.
7. Schneeweiss S. Confounding. In: Hartzema A, Tilson H, Chan K, eds. Pharmacoepidemiology and Therapeutic Risk Management. 4th ed. Cincinnati: Harvey Whitney; 2008:273-300.
8. Sackett DL. Bias in analytic research. J Chronic Dis. 1979; 32:51-63.
9. Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Community Health. 2004; 58:635-41.
10. Gail MH, Benichou J. Encyclopedia of epidemiologic methods. New York: Wiley; 2000.
11. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, CA: Lifetime Learning; 1982.
12. Last JM, ed. A dictionary of epidemiology. 4th ed. New York: Oxford Univ. Press; 2001.
13. Taylor AL, Wright JT Jr. Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Circulation. 2005; 112:3654-60,3666.
14. BiDil (isosorbide dinitrate and hydralazine hydrochloride) package insert. Lexington, MA: NitroMed; 2005.
15. Machin D, Day S, Green SB. Textbook of clinical trials. 2nd ed. Hoboken, NJ: Wiley; 2006.
16. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004; 15:615-25.
17. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007; 16:241-9.
18. Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med. 2003; 168:49-53.
19. Glynn RJ, Schneeweiss S, Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006; 98:253-9.
20. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997; 127(8, pt. 2):757-63.
21. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000; 11:550-60.
22. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998; 338:1516-20.
23. Ray WA, Daugherty JR, Griffin MR. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev. 2002; 8:276-9.
24. Setoguchi S, Glynn RJ, Avorn J et al. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007; 115:27-33.
25. Ray WA, Meredith S, Thapa PB et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004; 75:234-41.
26. Martens EP, Pestman WR, de Boer A et al. Instrumental variables: application and limitations. Epidemiology. 2006; 17:260-7.
27. Stukel TA, Fisher ES, Wennberg DE et al. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007; 297:278-85.
28. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003; 158:915-20.
29. Yusuf S, Negassa A. Choice of clinical outcomes in randomized trials of heart failure therapies: disease-specific or overall outcomes? Am Heart J. 2002; 143:22-8.